Intravenous administration of adipose-derived mesenchymal stem cells can be applied for patients with hepatic cirrhosis at Medical corporation Kaizuka hospital from October 2016.
Please click the link below for more details.
Patient recruitment was completed in September 2019.
Inquiry by Phone
(Mon.-Fri. 9:00 a.m.-5:15 p.m., JST)
Inquiry by Email